3-hydroxyflavone has been researched along with Dyslipidemias in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Dai, X; Feng, J; Ge, C; Hu, LF; Kuang, Q; Lai, L; Li, H; Long, T; Sun, Y; Tan, J; Tang, T; Xiong, M; Xu, M; Yang, Q; Yi, C; Zhan, J; Zhong, S | 1 |
1 other study(ies) available for 3-hydroxyflavone and Dyslipidemias
Article | Year |
---|---|
Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Echocardiography; Fibrosis; Flavonoids; Flavonols; Glucose Tolerance Test; Heart; Heart Diseases; Inflammation; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction | 2020 |